Philippines Current Affairs - 2020

Rodrigo Duterte sworn in as President of Philippines

Rodrigo Duterte was sworn in as the 16th President of Philippines. He will have tenure of six years. He was administered oath to the office by the Supreme Court justice at the Malacanang presidential palace About Rodrigo Duterte Born on March 28, 1945 in Maasin, Leyte into a political family with a modest background. By Read More…

Rodrigo Duterte wins 2016 Philippines Presidential Election

Anti-crime candidate and mayor of Davao City, Rodrigo Duterte has won the 2016 presidential election of the Philippines by a landslide victory. He will become the 16th President-elect of Philippines. In the Presidential election held on 9 May 2016, Rodrigo Duterte secured 39% (15.36 million) of the votes. He was followed by Mar Roxas 23% Read More…

World’s first public dengue vaccination programme launched in Philippines

The world’s first public dengue vaccination programme was launched in the Philippines with a French drug Dengvaxia (world’s 1st dengue fever vaccine) to combat mosquito-borne disease. Several hundred children aged between 9 and 10 were vaccinated with the injections in front of government health workers at a public school in eastern Manila. Mexico was first Read More…

Union Government imposes anti-dumping duty on Plastic-Processing imports

Union Government has imposed anti-dumping duty of up to 44.7 per cent on import of plastic-processing machines from Chinese Taipei, Malaysia, Philippines and Vietnam for five years. The anti-dumping duty will be levied on imports of all kinds of plastic-processing or injection-moulding machines, also known as injection presses. The move is aimed at protecting the Read More…

Philippines becomes first Asian country to approve sale of dengue vaccine Dengvaxia

Philippines became the first Asian country to approve the sale of the world’s first ever dengue vaccine Dengvaxia in the country. The Dengvaxia vaccine has been manufactured by French pharmaceutical manufacturer Sanofi Pasteur. It has been designed to protect people in the 9-45 age groups from all four subtypes of the virus. Key facts The Read More…